February 09, 2023
Back Page
43
02
Their integration across enterprise remains pivotal driver for success.
February 09, 2023
Features
43
02
Branding agency experts share what to know when it comes to legal, regulatory, and creative approaches in the complex drug-naming process, with its potential to shape a campaign’s success.
February 09, 2023
Features
43
02
A survey of 18 biopharmas, measuring their scope and implementation across key health equity dimensions and activities, uncovers useful context as companies seek better alignment of these goals with overall strategy.
February 09, 2023
Features
43
02
Health disparities brought on by racial bias remain quite prevalent in areas such as drug access, use of diagnostics, and representation in clinical trials, but society-jarring events in recent years have sparked renewed efforts by industry to tackle these issues with tangible and hopeful gains.
February 09, 2023
Executive Roundtable
43
02
Chief financial officers and other finance experts discuss the continued market volatility impacting life sciences investment—and what biopharma companies can do to help accelerate its recovery. Quality science and “good data” still win the day.
February 09, 2023
Executive Profile
43
02
Starting out with limited pharma business knowledge, how the lessons learned and realizations made helped to forge a destined—and globe-spanning—leadership path for Christophe Bourdon, where today, as CEO of LEO Pharma, he is tasked with steering the longtime company’s return to profitability.
February 09, 2023
Finance
43
02
Chronicling the market’s rise and fall—and signs of potential recovery.
February 09, 2023
Technology
43
02
Biopharma insiders believe it’s time to invest in technology again.
February 09, 2023
ESG
43
02
Examining efforts to boost women representation on company boards.
February 09, 2023
Europe Report
43
02
Is agenda blurring the line between alliances and assimilation?
February 09, 2023
Washington Report
43
02
Probe targets agency’s role in advising on drug testing and submissions.
February 09, 2023
From the Editor
43
02
Pharm Exec's February issue focuses on health equity.